LIFE CYCLE FIRMS
SPONSORED BIOGRAPHIES
JEFFRY S. MANN, Ph.D. MORGAN LEWIS One Market, Spear Street Tower San Francisco, CA 94105-1596 Tel: 415 442 1119 Email: [email protected] Web: www.morganlewis.com MORGAN LEWIS 1111 Pennsylvania Ave., NW Washington, DC 20004-2541 Tel: 202 739 5205 Email: [email protected] Web: www.morganlewis.com
STEPHEN PAUL MAHINKA
Stephen Paul Mahinka is the chair of Morgan Lewis’s Life Sciences and Healthcare Interdisciplinary Group, one of the nation’s largest. He also is a member of both the Antitrust Practice and the FDA Practice. Mr. Mahinka has practiced in both the antitrust and FDA regulatory areas throughout his career, and is the founder of the firm’s FDA Practice and a former leader of its Antitrust Practice. Mr. Mahinka’s FDA practice focuses on regulatory, transactional, and compliance matters throughout the product lifecycle, including approval, acquisition, licensing, marketing, distribution, pricing, and enforcement concerning prescription and OTC drugs, biologics, biosimilars, food and food additives, GRAS substances and packaging, medical devices, and dietary supplements; FTC, DOJ, and state investigations; Hatch-Waxman matters; FTC, FDA, and state consumer protection matters; joint venture matters regarding healthcare providers; and healthcare reform law issues. He has assisted with numerous life sciences transactions, including acquisitions, collaborations, and licensing. In the antitrust area, Mr. Mahinka’s practice includes counseling and litigation concerning mergers, joint ventures, and other collaboration agreements; pricing and price discrimination; marketing and advertising; monopolization; Department of Justice, Federal Trade Commission, and state investigations; FTC and state consumer protection issues; trade associations; and the application of antitrust laws to regulated industries, particularly life sciences and energy. Mr. Mahinka has published nearly 60 articles on antitrust and FDA/healthcare matters. He is a co-author of Food and Drug Law and Regulation (Food and Drug Law Institute, Second Edition 2011), of Life Sciences Mergers and Acquisitions (Aspatore, 2008), of Winning Antitrust Strategies (Aspatore, 2004), and of Top 20 Food and Drug Cases, 2012 & Cases to Watch, 2013 (Food and Drug Law Institute, 2013), and a contributing author of the ABA Antitrust Section’s Pharmaceutical Industry Antitrust Handbook (2009). Mr. Mahinka has presented more than 80 speeches on antitrust and FDA matters in the United States and Japan, at programs sponsored by such groups as the Food and Drug Law Institute, the American Bar Association’s Section of Antitrust Law, the B ????????????%????????=??????????????)???????????M?????????]????????1?????????????????I??????????????A??????????M??????????%!=-8?????)??????????????????????????????????d?????????????5??5????????????????????)????!??????U???????A??? ???-????????????????!?????1??M??????())??????L??5?????A?????????????5?????1???e?M??????????%??????????A???????A???????!???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????5????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????I??????????????????????????5???????????????????????????????????????????????????????????????? ???????Q???????????%??????????????????????????????????????????????????????????????????????????????????????????????????????!??????????????????????????????????A???????Y????%???????????????????????????????????????????????????????????? ?????5????M????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????%L?? ????????????????????????????????????5?????????????????????????????????????I????????????U?????????
??????????M???????????U
M?????????????????????????????????????????????????????????????????????????????%??????????????????????????????
??????5?????1?????????????5???????I????????M???????
???????5?????????????????????????????????????????????????????????????????????????????????????????????????????5??????????????????????????????????????I?????????U
M??????????????????????????????????????A????????????????U
M?????????5?????????????????????????????????????????A???????????????????????????????????????????????????????????????????????????5??????????????????????????UL??????????????????????????????????????????????????????????????????????!???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????%?????????5?????????????)????? ?????? ???U???????!???????????A???????????????????????????????????U?????????=???????????????????? L????????????????
?????????M???U???????M??????????????????5??????????????????????????
??????????????????????T?L??A????????Q???????=??????((???()15 ?1%?M
%9
L?????((0